Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
October 26, 2020

Coronavirus company news summary – Genesprint Group and Infrawear introduce Covid-19 swab test in EU – Imec to develop SARS-CoV-2 test based on exhaled breath

By Chloe Kent

Celltrion, a biopharmaceutical company, has received emergency approval from the US Food and Drug Administration (FDA) for its Covid-19 antigen diagnosis kit Sampinute. The testing kit uses a proprietary antibody-antigen technology, which delivers results in less than 10 minutes. Compared to existing RT-PCR tests, the Sampinute kit can deliver results with 94% accuracy.

Genesprint Group, a testing company, and Infrawear, testing and antibody kits provider, announced plans to introduce rapid antigen throat and mouth swab test for Covid-19 in the Europe. The test is CE marked and can deliver results in right minutes with 99.99% specificity.

Imec, a research and innovation hub, has commenced the development of a new test capable of detecting SARS-CoV-2 virus through a person’s exhaled breath. The test can deliver accurate results in less than five minutes. A prototype of the test is expected to be available for testing in 2021.

Related Companies

Content from our partners
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy